Navigation Links
Onyx Pharmaceuticals Announces Third Quarter 2009 Financial Results Teleconference and Webcast
Date:10/27/2009

EMERYVILLE, Calif., Oct. 27 /PRNewswire-FirstCall/ -- Onyx Pharmaceuticals, Inc. (Nasdaq: ONXX) today announced that it will host a webcast and teleconference with management to provide a general business overview, as well as to discuss third quarter 2009 financial results, on Tuesday, November 3, 2009, at 5:00 p.m. Eastern Time (2:00 p.m. Pacific Time). Financial results for the third quarter ended September 30, 2009 will be released earlier that day.

Interested parties may access a live webcast of the presentation on the company's website at: http://www.onyx-pharm.com/view.cfm/32/Event-Calendar

or by dialing 847-619-6547 and using the passcode 25674242. A replay of the presentation will be available on the Onyx website or by dialing 630-652-3044 and using the passcode 25674242 approximately one hour after the teleconference concludes. The replay will be available through December 3, 2009.

About Onyx Pharmaceuticals, Inc.

Onyx Pharmaceuticals, Inc. is a biopharmaceutical company committed to improving the lives of people with cancer. The company, in collaboration with Bayer HealthCare Pharmaceuticals, Inc., is developing and marketing Nexavar®, a small molecule drug. Nexavar is currently approved for the treatment of liver cancer and advanced kidney cancer. Additionally, Nexavar is being investigated in several ongoing trials in a variety of tumor types. For more information about Onyx, visit the company's website at www.onyx-pharm.com.

Nexavar® (sorafenib) tablets is a registered trademark of Bayer HealthCare Pharmaceuticals.

SOURCE Onyx Pharmaceuticals, Inc.


'/>"/>
SOURCE Onyx Pharmaceuticals, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1

Related medicine technology :

1. Cumberland Pharmaceuticals to Announce Third Quarter 2009 Financial Results on November 10, 2009
2. Intercept Pharmaceuticals Announces Positive Phase II Results for INT-747 as a Treatment for Primary Biliary Cirrhosis
3. Bellicum Pharmaceuticals Announces $4.5 Million in New Funding
4. BioMarin Acquires Huxley Pharmaceuticals, Inc.
5. Sagent Pharmaceuticals to Present at Two Upcoming Financial Conferences
6. Transdel Pharmaceuticals to Webcast Presentation at 4th Annual BIOCOM Investor Conference
7. Keryx Biopharmaceuticals, Inc. Announces Upcoming Poster Presentation of Zerenex (ferric citrate) for the Treatment of Hyperphosphatemia at the Upcoming American Society of Nephrology Renal Week Meeting in San Diego
8. Quark Pharmaceuticals Expands International Patent Protection for Compounds Targeting the RTP801 Gene
9. Inhibikase Therapeutics Discusses New Platform for Infectious Disease Pharmaceuticals at BIOCOM 2009
10. Potentia Pharmaceuticals Enters into Licensing and Purchase Option Agreements with Alcon
11. NGM Biopharmaceuticals Appoints Dr. Arthur D. Levinson, Former Genentech CEO, to its Board of Directors
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/27/2015)... Biopharmaceutical Industry Leads Manufacturing Sector in R&D Spending ... as the country,s manufacturing leader in innovation and economic ... to the  analysis , the industry had the highest ... accounting for 27 percent of average annual R&D spending ... on Medicare Part D - Medicare Part D ...
(Date:3/27/2015)... , March 27, 2015 A new report from ... America – Chile , ... are top targets for IVD firms.  The healthcare research firm ... into IVD strategies for the Latin American continent with a ... globally distributed supply operations. However, the country,s regional economic clout ...
(Date:3/27/2015)... , March 27, 2015 ... International Exhibition of Senior Care, Rehabilitation Medicine and Healthcare, ... senior service industry, will be held at Shanghai New ... On 25 February, 2015,  Implementation Suggestions on Encouraging Private ... Industry, which was jointly issued by the Ministry of ...
Breaking Medicine Technology:Week in Review: The Latest from PhRMA 2Kalorama: Beyond Brazil, Latin American IVD Market Grows 2Kalorama: Beyond Brazil, Latin American IVD Market Grows 3Kalorama: Beyond Brazil, Latin American IVD Market Grows 4CHINA AID, the 10th China International Exhibition of Senior Care, Rehabilitation Medicine and Healthcare to be held in April 2CHINA AID, the 10th China International Exhibition of Senior Care, Rehabilitation Medicine and Healthcare to be held in April 3CHINA AID, the 10th China International Exhibition of Senior Care, Rehabilitation Medicine and Healthcare to be held in April 4CHINA AID, the 10th China International Exhibition of Senior Care, Rehabilitation Medicine and Healthcare to be held in April 5CHINA AID, the 10th China International Exhibition of Senior Care, Rehabilitation Medicine and Healthcare to be held in April 6
... (telmisartan) against placebo, in reducing ... infarction, stroke and hospitalization for congestive heart ... receiving current standard of care, RIDGEFIELD, ... of the,TRANSCEND(TM)* trial demonstrated that treatment with ...
... Seven Korean medical centers to collaborate on studies of ... role of cell-mediated immunity, COLUMBIA, Md., Aug. 28 ... Woo Biotech, is delighted to be able to,announce our ... assay,for cell-mediated immunity at seven highly respected medical institutions,in ...
Cached Medicine Technology:TRANSCEND(TM) Trial Results Presented at European Society of Cardiology Congress and Published in The Lancet 2TRANSCEND(TM) Trial Results Presented at European Society of Cardiology Congress and Published in The Lancet 3TRANSCEND(TM) Trial Results Presented at European Society of Cardiology Congress and Published in The Lancet 4TRANSCEND(TM) Trial Results Presented at European Society of Cardiology Congress and Published in The Lancet 5TRANSCEND(TM) Trial Results Presented at European Society of Cardiology Congress and Published in The Lancet 6TRANSCEND(TM) Trial Results Presented at European Society of Cardiology Congress and Published in The Lancet 7Cylex Announces Plan for Multi-Center Trial of ImmuKnow(R) Assay in South Korea 2Cylex Announces Plan for Multi-Center Trial of ImmuKnow(R) Assay in South Korea 3
(Date:3/27/2015)... UK (PRWEB) March 27, 2015 DrugDev ... Melissa (Liss) Easy was named to the 2015 Philadelphia ... Under 40 list spotlights 40 dynamic, up-and-coming leaders less ... and community involvement. Winners are honored at an awards ... of the Philadelphia Business Journal. , Lyn Kremer, Publisher ...
(Date:3/27/2015)... Naples, FL and London, UK (PRWEB) March 27, 2015 ... solution, announced today that it has appointed Sean Fitzgerald, ... the role of Chief Operating Officer and Interim Chief ... Vice President of leading education technology innovator, EverFi, backed ... Eric Schmidt, and Twitter founder Evan Williams. Prior to ...
(Date:3/27/2015)... Operatic contenders and their avid audience ... 17th. The universally acclaimed baritone Sherrill Milnes will be ... Idol at The Merion in Evanston. The event is ... aspiring opera singers from around the country. “This is ... finest young talent in the country,” said Margaret Gergen, ...
(Date:3/27/2015)... March 27, 2015 Since September 2014, the ... his comeback tour after having been in retirement for a ... for the performer to return to touring, and concert events ... for Omaha will likely sell out for the two shows ... BuyCheapTicketsToEvents.com to view the inventory of discounted Garth Brooks ...
(Date:3/27/2015)... “ VXi BlueParott Reveal ” was featured on ... features the latest and coolest technology products available to ... for NewsWatch, conducted the review and shared with viewers ... of ambient noise. , Today, business is all about ... to any professional, voice calls are just as important. ...
Breaking Medicine News(10 mins):Health News:DrugDev Founder Melissa Easy is 2015 Philadelphia Business Journal 40 Under 40 Honoree 2Health News:GenSight Appoints Former Technology Executive as Chief Operating Officer 2Health News:Opera Idol Competition At The Merion In Evanston 2Health News:Garth Brooks Tickets for Omaha: BuyCheapTicketsToEvents.com Draws Customers by Discounting Prices on 2015 Tickets for Garth Brooks’ Tour Stops at CenturyLink Center 2Health News:A Device to Tune out Background Noise was Recently Featured on NewsWatch Television 2
... thrombosis, study says , MONDAY, July 20 (HealthDay News) ... or varicose veins that have become swollen and painful ... problem. , One-quarter of patients with superficial vein thrombosis ... thrombosis (DVT), a potentially life-threatening condition. , "The diagnosis ...
... foods, experts advise reading food labels , MONDAY, July 20 ... to hypertension, but it can also reduce the effectiveness of ... striking about these results is the degree of the effect," ... the University of Alabama at Birmingham, and a member of ...
... , , LOS ... announced that Caroline W. Nahas, managing director of the Southern California ... chair of the organization,s corporate board of directors. The appointment of ... important role. Nahas will replace outgoing board chair, Jeffrey M. Johnson, ...
... is one of only four sites across the country to ... The study will investigate the effectiveness of a chemotherapeutic agent, ... heat therapy) for treating recurrent chest wall breast cancer. ... of breast cancer on the chest wall, most commonly presenting ...
... ... Sports Week, parents asked to share their experiences and tips on keeping kids healthy and ... Minneapolis, ... are tossing video games and television aside as they enjoy the summer sun. While the ...
... , , NAPERVILLE, Ill., July ... (IHA) announced today that Maryjane A. Wurth, 53, Chief Operating Officer, ... the new president of IHA. Wurth succeeds Ken Robbins, who has ... year. She will assume her duties as IHA,s president in October. ...
Cached Medicine News:Health News:Vein Condition May Mask Serious Clot Disorder 2Health News:High-Salt Diet Dampens Effects of Blood Pressure Drugs 2Health News:High-Salt Diet Dampens Effects of Blood Pressure Drugs 3Health News:Caroline W. Nahas Named New Corporate Board Chair for United Way of Greater Los Angeles 2Health News:Caroline W. Nahas Named New Corporate Board Chair for United Way of Greater Los Angeles 3Health News:RI Hospital first in country to enroll patient in new study for recurrent chest wall breast cancer 2Health News:Treating Kids' Summertime Bumps, Bruises and Injuries with The Healthcare Scoop 2Health News:Treating Kids' Summertime Bumps, Bruises and Injuries with The Healthcare Scoop 3Health News:Maryjane A. Wurth Named New President of Illinois Hospital Association 2
The Snap-In Snap-Out-II Tip Inserts offer a large variety of configurations....
The Snap-In Snap-Out-II Tip Inserts offer a large variety of configurations....
This dissector offers dual-action jaws, which are long, tapered, and angled 30 to simplify even difficult laparoscopic dissection....
The Optima III 45 cm line of laparoscopic hand instruments is ideal for operative laparoscopic/endoscopic procedures or when a longer instrument is needed....
Medicine Products: